Navigation Links
Sequenom to Present at Two Financial Conferences in March
Date:3/3/2010

SAN DIEGO, March 3 /PRNewswire-FirstCall/ -- Sequenom, Inc. (Nasdaq: SQNM) today announced that Harry F. Hixson, PhD, chairman and interim CEO, will present an overview of the company at the following conferences in March.

  • ROTH 22nd Annual OC Growth Stock Conference
  • Location: The Ritz Carlton, Dana Point, CA
  • Presentation Date: Wednesday March 17, 2010
  • Presentation time: 9:00am P.T.

  • Barclays Capital 2010 Global Healthcare Conference
  • Location: Loews Miami Hotel, Miami, FL
  • Presentation date: Wednesday, March 24, 2010
  • Presentation time: 2:00pm E.T.

A live webcast and 30-day archive of these presentations will be available at http://ir.sequenom.com.

About Sequenom

Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to improving healthcare through revolutionary genetic analysis solutions. Sequenom develops innovative technology, products and diagnostic tests that target and serve discovery and clinical research, and molecular diagnostics markets. The company was founded in 1994 and is headquartered in San Diego, California. Sequenom maintains a Web site at http://www.sequenom.com to which Sequenom regularly posts copies of its press releases as well as additional information about Sequenom. Interested persons can subscribe on the Sequenom Web site to email alerts or RSS feeds that are sent automatically when Sequenom issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the Web site.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20040415/SQNMLOGO)

SOURCE Sequenom, Inc.

Back to top

RELATED LINKS
http://www.sequenom.com

'/>"/>

SOURCE Sequenom, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Sequenom Appoints Two New Board Members
2. SEQUENOM Announces Partnership With GeneWorks for Sales & Marketing of MassARRAY Systems and Applications in Australia
3. SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights
4. SEQUENOM Announces Launch of MassARRAY Compact 96 System
5. SEQUENOM to Hold First Quarter 2009 Financial Results Conference Call on April 30
6. Webcast Alert: Sequenom: Defining the Future of Noninvasive Prenatal Diagnostics
7. Sequenom to Webcast Analyst and Investor Briefing Presentation on June 3
8. Sequenom to Webcast Analyst and Investor Briefing Presentation on September 24
9. Sangamo BioSciences Announces Presentation at Cowen and Company Health Care Conference
10. Tianyin Pharmaceutical Co., Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing on March 9
11. VIVUS to Present at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... ... June 20, 2017 , ... ... antibody therapeutics from millions-diverse immune repertoires, announces launch of its new Surge(TM) ... Dave Johnson, PhD, CEO of GigaGen, will present on Surge at the conference. ...
(Date:6/19/2017)... ... June 19, 2017 , ... Tunnell Consulting has ... years. One of the biggest challenges faced by life sciences, biotech and pharmaceuticals companies ... team is Kati Abraham , who is well known in the industry and ...
(Date:6/16/2017)... ... June 16, 2017 , ... ... solutions, today announced that its Anzo Smart Data Lake® (Anzo SDL) solution ... category for the 2017 Software & Information Industry Association (SIIA) CODiE Awards. ...
(Date:6/15/2017)... ... June 15, 2017 , ... Cybrexa Therapeutics, ... B round of financing in the amount of $6 million. An investment vehicle ... in the round. , The Series B funding will enable Cybrexa to complete ...
Breaking Biology Technology:
(Date:4/6/2017)... April 6, 2017 Forecasts by ... Document Readers, by End-Use (Transportation & Logistics, Government & ... Gas & Fossil Generation Facility, Nuclear Power), Industrial, Retail, ... Are you looking for a definitive report ... ...
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC ... announced that the United States Patent and Trademark Office ... broadly covers the linking of an iris image with ... transaction) and represents the company,s 45 th issued ... patent is very timely given the multi-modal biometric capabilities ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
Breaking Biology News(10 mins):